Johns Hopkins 21st Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases 2025

Date & Location Friday, September 12, 2025, 7:00 AM – Saturday, September 13, 2025, 5:00 PM, Johns Hopkins Tilghman Room, Baltimore, MD
Target Audience Specialties – Rheumatology

Overview
Now in its 21st year, this two-day symposium has been planned for the providers who care for patients with rheumatic disease. Given the wide variety of rheumatologic disorders, and an ever increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Objectives

Identify new treatment strategies in lupus nephritis.
Describe screening metrics for steroid induced osteoporosis and outline potential treatment paradigms.
Recognize the different subtypes of juvenile idiopathic arthritis (JIA).
Characterize new drugs for pulmonary hypertension in autoimmune disease.
Distinguish new and novel treatments for psoriatic arthritis.

The Johns Hopkins 21st Annual Advances in the Diagnosis and Treatment of the Rheumatic Diseases 2025 is best for clinicians—especially rheumatologists, internists, primary care physicians, nurse practitioners, physician assistants, and allied health professionals—who manage patients with rheumatic and autoimmune disorders and want the latest evidence-based updates.
Who Should Attend

Rheumatologists and internists seeking updates on diagnostic tools and treatment strategies
Primary care physicians who frequently encounter musculoskeletal and autoimmune conditions
Nurse practitioners, physician assistants, and allied health professionals involved in patient care and disease management
Residents, fellows, and trainees preparing for board exams or expanding their clinical knowledge
Researchers and educators interested in advances in rheumatology and translational science

What You’ll Learn
This two-day symposium provides a comprehensive review of rheumatologic disorders with a focus on practical application. Key highlights include:

Early diagnosis strategies for complex autoimmune and inflammatory conditions
Updates on novel diagnostic procedures and imaging tools
Advances in biologic therapies, immunomodulators, and precision medicine
Management of systemic lupus erythematosus, rheumatoid arthritis, vasculitis, spondyloarthropathies, and other rheumatic diseases
Case-based discussions to improve clinical decision-making and patient outcomes

+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
Friday, September 12, 2025

7:15 – 7:55 Registration and Continental Breakfast
7:55 – 8:00 Introductions Clifton Bingham III, MD
8:00 – 9:00 Advances in Lupus Andrea Fava, MD
9:00 – 10:00 Sjogren’s Update Thomas Grader-Beck, MD
10:00 – 10:15 Refreshment Break
10:15 – 11:15 Keynote Speaker, The Future of Rheumatology Antony Rosen, MD
11:15 – 12:00 Update on Lyme Disease John Miller, MD
12:00 – 1:00 Lunch Break and Meet the Professor
1:00 – 1:05 Introduction Uzma J. Haque, MD
1:05 – 2:05 Updates in SpA Atul Deodhar, MD
2:05 – 3:05 JIA updates Julia Shalen, MD
3:05 – 3:25 Refreshment Break
3:20 – 4:05 Update in Osteoporosis Kendall Mosby, MD
4:05 – 4:50 Fatigue Management Alba Azola, MD

Saturday, September 13, 2025

7:15 – 7:55 Registration and Continental Breakfast
7:55 – 8:00 Introductions Timothy Kaniecki, MD
8:00 – 8:45 Immune Checkpoint Update Laura Cappelli, MD
8:45 – 9:30 Malignancies and Rheumatic Disease Chris Mecoli, MD, MHS
9:30 – 9:45 Refreshment Break
9:45 – 10:45 Updates in Psoriatic Arthritis Ana-Maria Orbai, MD, MHS
10:45 – 11:45 Updates in Scleroderma Vascular Disease and Pulmonary Hypertension Catherine Simpson, MD
11:45 – 12:45 Lunch Break and Meet the Professor
12:45 – 12:50 Introductions Jamie Bond
12:50 – 1:50 Vasculitis Updates Brendan Antiochos, MD
1:50 – 2:50 Updates on CAR-T cells and Bispecific Antibody Therapies for Rheumatic Diseases Max König, MD
2:50 – 3:05 Refreshment Break
3:05 – 4:05 Rheumatoid Arthritis – What’s New in 2025 Clifton O. Bingham, MD
4:05 – 4:45 Difficult Cases Uzma Haque, MD and Timothy Kaniecki, MD
4:45 Adjourn You will receive an email notification to complete the evaluation form and to attest to the number of hours in attendance.